Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Selected Balance Sheet Data

v3.19.3.a.u2
Note 3 - Selected Balance Sheet Data
6 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Supplemental Balance Sheet Disclosures [Text Block]

Note 3. Selected Balance Sheet Data:

 

Inventories:

 

Inventories consist of (in thousands):

 

   

December 31,

   

June 30,

 
   

2019

   

2019

 

Raw materials

  $ 44,353     $ 40,913  

Finished goods(1)

    54,502       53,376  

Inventories, net

  $ 98,855     $ 94,289  

 

(1) Finished goods inventory of $3,504 and $3,239 is included within other long-term assets in the respective December 31, 2019 and June 30, 2019, consolidated balance sheet. The inventory is included in long-term assets as it forecasted to be sold after the 12 months subsequent to the consolidated balance sheet date.  

 

Property and Equipment:

 

Property and equipment consist of (in thousands):

 

   

December 31,

   

June 30,

 
   

2019

   

2019

 

Land

  $ 7,561     $ 7,065  

Buildings and improvements

    179,164       175,019  

Machinery and equipment

    139,814       124,233  

Property and equipment, cost

    326,539       306,317  

Accumulated depreciation

    (162,226

)

    (152,278

)

Property and equipment, net

  $

164,313

    $ 154,039  

 

Intangible Assets:

 

Intangible assets consist of (in thousands):

 

   

December 31,

   

June 30,

 
   

2019

   

2019

 

Developed technology

  $ 436,454     $ 435,679  

Trade names

    147,514       147,296  

Customer relationships

    214,434       214,320  

Patents

    2,309       2,133  

Intangible assets

    800,711       799,428  

Accumulated amortization

    (250,999 )     (219,999

)

Intangible assets, net

  $ 549,712     $ 579,429  

 

Changes to the carrying amount of net intangible assets for the six months ended December 31, 2019 consist of (in thousands):

 

Beginning balance

  $ 579,429  

Acquisitions

    -  

Other additions

    189  

Amortization expense

    (30,108

)

Currency translation

    202

 

Ending balance

  $ 549,712  

 

The estimated future amortization expense for intangible assets as of December 31, 2019 is as follows (in thousands):

 

2020 remainder

  $ 31,164  

2021

    60,162  

2022

    57,848  

2023

    55,976  

2024

    53,416  

Thereafter

   

291,146

 

Total

  $ 549,712  

 

Goodwill:

 

Changes to the carrying amount of goodwill for the six months ended December 31, 2019 consist of (in thousands):

 

   

Protein Sciences

   

Diagnostics and

Genomics

   

Total

 

Beginning balance

  $ 377,407       355,260     $ 732,667  

Acquisitions (Note 4)

    -       -       -  

Currency translation

    1,609       (35 )     1,574  

Ending balance

  $ 379,016     $ 355,225     $ 734,241  

 

We evaluate the carrying value of goodwill in the fourth quarter of each fiscal year and between annual evaluations if events occur or circumstances change that would indicate a possible impairment. The Company performed a goodwill impairment assessment for all of its reporting units during the fourth quarter of fiscal 2019. No indicators of impairment were identified as part of our assessment. 

 

No triggering events were identified during the six months ended December 31, 2019. There has been no impairment of goodwill since the adoption of Financial Accounting Standards Board (“FASB”) ASC 350 guidance for goodwill and other intangibles on July 1, 2002.